BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 35306527)

  • 1. Pyruvate kinase L/R links metabolism dysfunction to neuroendocrine differentiation of prostate cancer by ZBTB10 deficiency.
    Wen YC; Chen WY; Tram VTN; Yeh HL; Chen WH; Jiang KC; Abou-Kheir W; Huang J; Hsiao M; Liu YN
    Cell Death Dis; 2022 Mar; 13(3):252. PubMed ID: 35306527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting PKLR/MYCN/ROMO1 signaling suppresses neuroendocrine differentiation of castration-resistant prostate cancer.
    Chen WY; Thuy Dung PV; Yeh HL; Chen WH; Jiang KC; Li HR; Chen ZQ; Hsiao M; Huang J; Wen YC; Liu YN
    Redox Biol; 2023 Jun; 62():102686. PubMed ID: 36963289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autophagy pathway is required for IL-6 induced neuroendocrine differentiation and chemoresistance of prostate cancer LNCaP cells.
    Chang PC; Wang TY; Chang YT; Chu CY; Lee CL; Hsu HW; Zhou TA; Wu Z; Kim RH; Desai SJ; Liu S; Kung HJ
    PLoS One; 2014; 9(2):e88556. PubMed ID: 24551118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Castration-Induced Downregulation of SPARC in Stromal Cells Drives Neuroendocrine Differentiation of Prostate Cancer.
    Enriquez C; Cancila V; Ferri R; Sulsenti R; Fischetti I; Milani M; Ostano P; Gregnanin I; Mello-Grand M; Berrino E; Bregni M; Renne G; Tripodo C; Colombo MP; Jachetti E
    Cancer Res; 2021 Aug; 81(16):4257-4274. PubMed ID: 34185677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of TGF-β - SMAD2 signaling by IL-6 drives neuroendocrine differentiation of prostate cancer through p38MAPK.
    Natani S; Sruthi KK; Asha SM; Khilar P; Lakshmi PSV; Ummanni R
    Cell Signal; 2022 Mar; 91():110240. PubMed ID: 34986386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Neuropilin-1/PKC axis promotes neuroendocrine differentiation and drug resistance of prostate cancer.
    Blanc C; Moktefi A; Jolly A; de la Grange P; Gay D; Nicolaiew N; Semprez F; Maillé P; Soyeux P; Firlej V; Vacherot F; Destouches D; Amiche M; Terry S; de la Taille A; Londoño-Vallejo A; Allory Y; Delbé J; Hamma-Kourbali Y
    Br J Cancer; 2023 Mar; 128(5):918-927. PubMed ID: 36550208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunosuppressive role of BDNF in therapy-induced neuroendocrine prostate cancer.
    Liu YN; Chen WY; Liu MK; Yeh HL; Chen WH; Jiang KC; Li HR; Chen ZQ; Wang WH; Abou-Kheir W; Wen YC
    Mol Oncol; 2024 Jun; 18(6):1665-1686. PubMed ID: 38381121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CaV1.3 enhanced store operated calcium promotes resistance to androgen deprivation in prostate cancer.
    O'Reilly D; Downing T; Kouba S; Potier-Cartereau M; McKenna DJ; Vandier C; Buchanan PJ
    Cell Calcium; 2022 May; 103():102554. PubMed ID: 35193095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trigred motif 36 regulates neuroendocrine differentiation of prostate cancer via HK2 ubiquitination and GPx4 deficiency.
    Zhao X; Zhou T; Wang Y; Bao M; Ni C; Ding L; Sun S; Dong H; Li J; Liang C
    Cancer Sci; 2023 Jun; 114(6):2445-2459. PubMed ID: 36799474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel GRK3-HDAC2 regulatory pathway is a key direct link between neuroendocrine differentiation and angiogenesis in prostate cancer progression.
    Naderinezhad S; Zhang G; Wang Z; Zheng D; Hulsurkar M; Bakhoum M; Su N; Yang H; Shen T; Li W
    Cancer Lett; 2023 Sep; 571():216333. PubMed ID: 37543278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secretogranin II is overexpressed in advanced prostate cancer and promotes the neuroendocrine differentiation of prostate cancer cells.
    Courel M; El Yamani FZ; Alexandre D; El Fatemi H; Delestre C; Montero-Hadjadje M; Tazi F; Amarti A; Magoul R; Chartrel N; Anouar Y
    Eur J Cancer; 2014 Nov; 50(17):3039-49. PubMed ID: 25307750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of neuroendocrine differentiation in castration resistant prostate cancer cells by adipocyte differentiation-related protein (ADRP) delivered by exosomes.
    Lin LC; Gao AC; Lai CH; Hsieh JT; Lin H
    Cancer Lett; 2017 Apr; 391():74-82. PubMed ID: 28109910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. REST reduction is essential for hypoxia-induced neuroendocrine differentiation of prostate cancer cells by activating autophagy signaling.
    Lin TP; Chang YT; Lee SY; Campbell M; Wang TC; Shen SH; Chung HJ; Chang YH; Chiu AW; Pan CC; Lin CH; Chu CY; Kung HJ; Cheng CY; Chang PC
    Oncotarget; 2016 May; 7(18):26137-51. PubMed ID: 27034167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HOTAIR is a REST-regulated lncRNA that promotes neuroendocrine differentiation in castration resistant prostate cancer.
    Chang YT; Lin TP; Tang JT; Campbell M; Luo YL; Lu SY; Yang CP; Cheng TY; Chang CH; Liu TT; Lin CH; Kung HJ; Pan CC; Chang PC
    Cancer Lett; 2018 Oct; 433():43-52. PubMed ID: 29944905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ADT with antiandrogens in prostate cancer induces adverse effect of increasing resistance, neuroendocrine differentiation and tumor metastasis.
    Niu Y; Guo C; Wen S; Tian J; Luo J; Wang K; Tian H; Yeh S; Chang C
    Cancer Lett; 2018 Dec; 439():47-55. PubMed ID: 30227222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of EHF facilitates the development of treatment-induced neuroendocrine prostate cancer.
    Long Z; Deng L; Li C; He Q; He Y; Hu X; Cai Y; Gan Y
    Cell Death Dis; 2021 Jan; 12(1):46. PubMed ID: 33414441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TRIM59 is suppressed by androgen receptor and acts to promote lineage plasticity and treatment-induced neuroendocrine differentiation in prostate cancer.
    Fan L; Gong Y; He Y; Gao WQ; Dong X; Dong B; Zhu HH; Xue W
    Oncogene; 2023 Feb; 42(8):559-571. PubMed ID: 36544044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroendocrine Differentiation of Prostate Cancer-An Intriguing Example of Tumor Evolution at Play.
    Patel GK; Chugh N; Tripathi M
    Cancers (Basel); 2019 Sep; 11(10):. PubMed ID: 31547070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-1205 Regulation of FRYL in Prostate Cancer.
    Naidoo M; Levine F; Gillot T; Orunmuyi AT; Olapade-Olaopa EO; Ali T; Krampis K; Pan C; Dorsaint P; Sboner A; Ogunwobi OO
    Front Cell Dev Biol; 2021; 9():647485. PubMed ID: 34386489
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Fararjeh AS; Liu YN
    Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31181727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.